Reuters logo
BRIEF-Oryzon Genomics begins phase I study for small cell lung cancer
January 9, 2017 / 12:33 PM / 8 months ago

BRIEF-Oryzon Genomics begins phase I study for small cell lung cancer

Jan 9 (Reuters) - Oryzon Genomics SA :

* Enrolls first patient for phase I clinical trial for RG6016 for small cell lung cancer for study carried out by Roche

Source text: bit.ly/2iV8Mk8

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below